الفهرس | Only 14 pages are availabe for public view |
Abstract Morbid obesity is now an important problem all over the world due to its multiple co-morbidities and its marked harmful effect on the lifestyle of the patient. Surgical treatment for obesity has proved that it is the best and most effective, durable means of preventing the life-threatening complications and serious problems associated with morbid obesity. It is indicated by the ineffectiveness of non-surgical treatment methods and the high risk resulting from untreated obesity. Safe and effective surgical treatment methods increase life expectancy and quality for patients with extreme excess weight. Operations for morbid obesity have developed over the last 50 years, based on malabsorption, gastric restriction and a combination of both. These operations are being extended into laparoscopic realm. Both LRYGB and LMGB are effective for morbid obesity with similar results for resolution of metabolic syndrome and improvement of quality of life. Laparoscopic Roux-en-Y gastric bypass (LRYGB) is considered the gold standard for the treatment of morbid obesity but is technically challenging and results in significant perioperative complications. Laparoscopic mini-gastric bypass is a simpler and easier to perform than RYGB; however, long-term data are still needed to determine whether it can match RYGB in terms of sustained weight reduction, and also whether there is an increased incidence of long-term complications such as biliary reflux, marginal ulceration and reflux oesophagitis. |